| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |